1.
Preparation of irinotecan hydrochloride containing liposomes by ammonium sulfate gradient method and its release in vitro
硫酸铵梯度法制备盐酸伊立替康脂质体及体外释放的研究
2.
Pharmacokinetic Study of Irinotecan by Co-administered Thalidomide;
合用沙利度胺对盐酸伊立替康药代动力学影响的研究
3.
Preparation and quality evaluation of irinotecan hydrochloride lyophilized liposomes
盐酸伊立替康脂质体冻干粉针的制备及其质量评价
4.
Determination of Residual Solvents in Irinotecan Hydrochloride by Gas Chromatography
气相色谱法测定盐酸伊立替康原料中的溶剂残留
5.
Determination of Myristoyl in Irinotecan Hydrochloride Liposome Injection by HPLC
HPLC法测定盐酸伊立替康脂质体注射液中的溶血卵磷脂
6.
Clinical Observation of Candidal Balanitis Treated with Butenafine Hydvochloride Cream and Sporanox
盐酸布替萘芬乳膏联合伊曲康唑治疗念珠菌性龟头炎临床观察
7.
Irinotecan in the Treament of Small Cell Lung Cancer (SCLC): A Systematic Review
伊立替康治疗小细胞肺癌的系统评价
8.
Effect of Irinotecan Combined with Radiotherapy in Patients with Advanced Non-small Cell Lung Cancer
伊立替康联合放疗治疗晚期NSCLC的疗效
9.
Aim To improve the preparation process of topotecan hydrochloride.
目的改进盐酸拓扑替康的合成方法。
10.
Investigation on the pharmacokinetics of iv gtt single and multi-dose roxatidine acetate hydrochloride injection in healthy volunteers
注射用盐酸罗沙替丁醋酸酯健康人体的药动学
11.
Irinotecan plus fluorouracil/leucovorin in the treatment of advanced colorectal cancer
伊立替康与氟尿嘧啶/亚叶酸钙方案治疗转移性结直肠癌的临床观察
12.
Clinical comparison between single agent of irinotecan and combination of irinotecan and cispaltin in second-line treatment of small cell lung cancer
伊立替康单药与伊立替康联合顺铂二线治疗小细胞肺癌的临床比较
13.
Preparation of Irinotecan Hydrochloride Liposome and the in Vitro and in Vivo Pharmaceutical Behaviors of Irinotecan Liposome;
伊立替康脂质体的制备及体内外行为研究
14.
Determination of Stabilization of Irinotecan in 0.9% Sodium Chloride Injection by HPLC
伊立替康浓度测定及其输液稳定性考察
15.
Clinical Study of Advanced Ovarial Cancer with Irinotecan and Cisplatin Regimen Combination
伊立替康联合顺铂治疗晚期卵巢癌的疗效观察
16.
The Efficacy Observation of Irinotecan Therapy of Patients with Recurrent Advanced Ovarian Carcinoma
伊立替康治疗复发性晚期卵巢癌的临床观察
17.
CLINICAL OBSERVATION ON THE IRINOTECAN PLUS CISPLATIN FOR ADVANCED ESOPHAGEAL CANCER
伊立替康联合顺铂治疗晚期食管癌疗效观察
18.
Irinotecan combined with capecitabine in line-2 treatment of locally advanced or metastatic gastric cancer
伊立替康联合卡培他滨二线治疗晚期胃癌